ASAP BioPharma Conference

How Alliance Managers Can Deliver Strategic Value to the Executive Level, Cindy Warren, Tracy Blois, Tomoko Hanadate

As the boundaries between business development and alliance management blur, a new generation of alliance leaders is stepping up to deliver more strategic value—before, during, and long after the deal is signed.

This panel will bring together Chief Business Officers and senior alliance leaders from biopharma, biotech, and health tech to explore how alliance management is evolving into a strategic advisory function. Panelists will share perspectives from both the C-Suite and the alliance desk, revealing how alliance professionals can better anticipate needs, strengthen feedback loops, and position themselves as indispensable partners in driving organizational success.

Key Takeaways

• Feedback Loops that Matter: How to create effective two-way communication with senior leadership.
• What the C-Suite Values Most: Insights from Chief Business Officers on what truly drives impact.
• Elevating Your Role: Concrete ways alliance managers can demonstrate and expand their value.
• What Your Boss Wishes You Knew: Unspoken expectations and lessons that can accelerate your growth.

Exploring New Alliance Models: A Thesis on Building Alliance Capabilities in Emerging Life Science Companies, Nancy Griffin

Emerging life science companies face unique challenges when entering into inter-firm collaborations for the first time. This presentation will provide an overview of the research conducted and the associated results from a study that was carried out in support of a Doctoral Dissertation to investigate the experiences of alliance organizations engaging in first time collaborations. The outcomes of the study lead to the development of a knowledge framework designed to facilitate the learning and embedding of new ways of working in collaborations. Developed on the basis of adult learning principles, the framework directs new alliance practitioners through guiding questions built around four strategic dimensions to arrive at customized deliverables in support of alliance best practice outcomes

Revolutionizing Contract Management: GenAI Solutions Tailored for Alliance Managers, Sumeet Bagga

Discover how Merck developed an AI-powered system that transformed chaotic manual processes into a streamlined, intelligent solution for alliance management. Learn about the technical approach, implementation challenges, and measurable business impact of applying AI to real-world enterprise data management.

Alliance Management Impact and the Importance of Publishing Our Work, Brian Stewart

Transform your alliance management function from an invisible contributor to a recognized strategic partner. In this essential session, you'll learn proven strategies for elevating alliance management's visibility and demonstrating its measurable value across your organization. We'll explore effective methods for documenting and publishing your work, ensuring your critical contributions are seen and understood. You'll discover best practices for communicating impact to key stakeholders, along with practical approaches for sharing insights both within your department and across the broader organization. Most importantly, you'll gain the tools needed to build lasting recognition for alliance management as a strategic function that drives business success. Join us to ensure your critical work finally gets the visibility and appreciation it deserves, positioning you and your team as indispensable strategic partners in your organization's growth.

From Manager to Confidant: Evolving Your Role as Alliance Manager Into a Trusted Advisor, Adam Kornetsky, Carol Bonett

As deal structures become increasingly complex, alliance leaders must evolve from behind-the-scenes operators to strategic enablers and trusted advisors to senior leadership. This session explores how to transcend traditional roles and establish yourself as an indispensable strategic partner, drawing from Vantage's proven Trusted Advisor framework and insights from high-performing organizations. Learn the essential behaviors, competencies, and mindsets that build executive credibility and influence, while discovering practical strategies for shifting from reactive problem-solver to proactive value creator. Whether you're a seasoned professional ready to elevate your impact or newcomer eager to fast-track your strategic voice, you'll gain actionable guidance for speaking the language of leadership and becoming the go-to advisor your organization needs at the executive table.

When Equal Isn't Equal: Cracking the Code of 50:50 Alliances,  Andi Gardner, Carl Olson

Pharmaceutical 50:50 alliances are often positioned as a powerful model for value creation—bringing together complementary strengths, balancing investment and risk, and promising co-funded innovation with shared accountability. When managed effectively, they accelerate development timelines, expand market access, and deliver meaningful patient and business outcomes.

 Equal ownership, however, does not guarantee equal vision or seamless execution. If not thoughtfully designed and actively managed, alliances can encounter governance friction, cultural disconnects, or competing priorities. These risks become most evident as partnerships advance toward commercialization, where decisions on go-to-market strategy, pricing, reimbursement, and capital allocation attract heightened executive attention. In such moments, equal funding without clear decision rights may slow momentum or create frustration across stakeholders.

The good news is that these pitfalls are not inevitable. With the right structures and leadership, 50:50 alliances demonstrate resilience and impact. This session shows how alliance managers, executive sponsors, and cross-functional teams turn complexity into collaboration.

Participants will gain practical insights into the enablers of success, including:

• Selecting and empowering high-performing alliance managers.
• Establishing lean governance models with clarity of authority.
• Sustaining active executive sponsorship throughout the alliance life cycle.

 Attendees will leave with strategies to anticipate challenges, strengthen alignment, and unlock the full potential of 50:50 alliances.

BREAKOUT TRACKS

Embracing Digital Dexterity for Alliance Management, Helena Cowley, Dhruv Desai, Andrew Ferguson, Nick Heath, Kristin Rosner

This collaborative session moves beyond presentations to create meaningful peer-to-peer learning, empowering participants to unlock the full potential of digital tools, drive organizational innovation, and elevate alliance management effectiveness through enhanced digital capabilities. Come ready to contribute your insights and leave with actionable strategies for advancing digital dexterity across your alliance management practice. 

Measuring Success and Driving Continuous Improvement in an Alliance, Frederic Bonfils

To ensure the maximum value from strategic alliances, establishing clear and measurable criteria of the value and relevant feedback loops is critical to ensure continuous improvement.  This presentation will review the management of an Alliance portfolio and the different proposed criteria and KPIs (R&D or Go to market Alliances). Presentation will include strategies to improve the performance of an alliance from the set up (determining the alliance objectives and providing tools to support the teams in the daily collaboration) to the regular monitoring of the alliance performance, including a specific focus on Healthchecks, with real life experience, tips and tricks. Key learnings will be best practices for both measuring value and ensuring improvement for alliances.

Practical Considerations for a Successful and Stress-Free Launch, Brian Lam

Alliance Managers hold the key to seamless partnership launches, but success begins long before contract signing with careful attention to often-overlooked "customizable" contract details that can dramatically reduce launch stress for both parties in research collaborations. This practical session explores critical contract formation considerations including JSC membership optimization (determining the right participants and committee size), governance structure decisions (when is a JRC truly necessary versus optional?), strategic launch timing (avoiding year-end complications), and immediate post-contract obligations (managing materials transfers and data deliverables from day one). Learn how to identify and negotiate these seemingly minor but mission-critical elements during contract formation to ensure your organizational and partnership needs align perfectly, enabling you to deliver smooth, successful launches that set the foundation for long-term collaborative success.

Daiichi Sankyo & Merck Oncology Collaboration, Moderated by Jill McGuinn with Ryo Arakane, Lisa Blair, Christine David, Rina Matsushima, Josh Miller

A panel discussion featuring leaders from Daiichi Sankyo and Merck, highlighting their collaboration on pharma’s largest collaboration, inclusive of four (4) oncology assets in a global co-development and co-commercialization. The session will cover key topics, including governance models, communication tools, and effective cross-asset collaboration. Relatable experiences and practical takeaways will be shared to enhance future partnerships.

From Set-Up to Scale-Up: Practical Lessons in Managing High Impact Alliances, Beatrice Lana

Drawing from extensive experience leading both small-scale drug discovery collaborations and large, multi-stakeholder partnerships involving academic institutions, pharmaceutical companies, and charities, this session explores practical alliance management across diverse business models and partnership structures. Learn how to apply best practices throughout the partnership life cycle—from using charters to align expectations and conducting proactive health checks to maintaining risk registers that drive strategic decision-making—while discovering strategies for transforming under performing alliances into successful new models that meet evolving partner needs. Using real-world examples including the Cancer Research Horizons-AstraZeneca Functional Genomics Centre—a capability platform partnership designed to democratize access to world-class functional genomics tools—explore how to manage multi-layered governance structures, coordinate diverse stakeholders from bench scientists to C-suite executives, execute complex agreement portfolios, and maintain financial alignment across partners while delivering strategic value through structured coordination and effective cross-functional communication.

Transition Break

BREAKOUT TRACKS

Due Diligence and Negotiation: Early Involvement of Alliance Managers for Future Successful Partnerships , Virginie Gurson, Romuald Laine

The role of an alliance manager has evolved significantly due to industry changes, technological advancements, and business needs. The role has become more strategic, requiring a long-term vision to anticipate market trends. Overall, the role demands adaptability and agility in responding to a constantly changing environment and seizing new opportunities.

At Servier the Alliance Managers are involved in the Due Diligence coordinating the whole R&D team. By giving an overview of the process, we’ll present the role of AMs before, during and after the due diligence.

We’ll share use cases where the AMs:

• Influenced the drafting of the Non-Binding Offer and final contract.
• Are leading the drafting of the Transition Plan with the partner.
• gain exposition by Presenting to the Governance the recommendation from R&D

We’ll finally discuss how we can influence the organization to involve the AM in such process.

Takeaways:

The Next Era of Digital Health:  Global Innovation for a Healthier World, Timothy Hsiao

Biopharma acquisitions, including those evolving from existing collaborations, present unique challenges for alliance leaders as they implement solutions to achieve successful mergers. This presentation will highlight two case studies of small biotech acquisitions exploring challenges such as cybersecurity issues, data privacy concerns, and issues in clinical trial operations. Solutions for common process issues such as integration delays and siloed work will also be addressed. Learnings from these success scenarios provide guidance for identifying challenges and implementing solutions applicable for alliance leaders and their partner functions of BD, HR, IT, Quality and senior leadership.

Formation and Execution of a Cross-Industry, Multi-Partner Alliance Accelerating Drug Discovery Using Genomic and Medical Record Data, Maegan Harden, Katherine Ellison

The Alliance for Genomic Discovery (AGD) represents a breakthrough in cross-industry collaboration—a 10-partner alliance between Illumina, Nashville Biosciences, and 8 pharmaceutical companies that successfully delivered whole genome sequence and EMR data for 250,105 individuals to accelerate drug discovery across competing organizations. This session explores how alliance management principles enabled the creation of a novel governance structure featuring an Alliance Council with representation from all partners, subject matter expert-led technical meetings, and a customized data storage solution addressing complex security, privacy, and sharing restrictions. Learn how strategic alliance design transcended traditional competitive barriers to generate a shared data resource available to all partners for their individual drug discovery pipelines, demonstrating a new model for industry collaboration that delivers collective value while respecting individual competitive interests.

Best Practices for Evolving Collaborations, Partnerships, and Acquisitions Into Successful Mergers, Tressa Allington

Biopharma acquisitions, including those evolving from existing collaborations, present unique challenges for alliance leaders as they implement solutions to achieve successful mergers. This presentation will highlight two case studies of small biotech acquisitions exploring challenges such as cybersecurity issues, data privacy concerns, and issues in clinical trial operations. Solutions for common process issues such as integration delays and siloed work will also be addressed. Learnings from these success scenarios provide guidance for identifying challenges and implementing solutions applicable for alliance leaders and their partner functions of BD, HR, IT, Quality and senior leadership.

Community Lunch

BREAKOUT TRACKS

From Collaboration to Publication: Aligning Disclosure in High-Stakes Biopharma Alliances, Celine Hechard, Doug Williams

Navigate the strategic minefield where partnership transparency meets competitive advantage in this highly interactive session focused on disclosure management challenges that define successful biopharma alliances. Alliance management leaders will guide participants through a compelling real-world case study that illuminates the complex tensions and critical trade-offs inherent in joint publication planning, followed by facilitated small-group discussions where attendees tackle similar dilemmas including coordinating cross-company authorship, resolving timing misalignments, and managing conflicting messaging strategies. Through peer collaboration and expert facilitation, participants will develop practical, field-tested tools and strategies for successfully navigating disclosure challenges while maintaining both scientific integrity and essential partnership trust—essential skills for any alliance professional managing the delicate balance between collaboration and competition.

Track 2

Building a Scalable Model for Asset Close-out and Out-Licensing Readiness, Delira Robbins

1:15 - 1:35

As biopharma portfolios evolve, the need for structured, cross-functional asset close-out and out-licensing processes has become increasingly critical. The Asset Close-Out and Transition Team (ACTT) at Amgen was established to address this need by creating a scalable, repeatable model that ensures operational continuity, legal compliance, and strategic readiness for out-licensing opportunities. This presentation will explore how ACTT integrates alliance management, regulatory, clinical, operations, and legal functions to streamline transitions, reduce risk, and preserve asset value. Lessons learned from recent transitions, including how ACTT supports due diligence, manages data room readiness, and translates deal terms into actionable execution plans will be shared. Attendees will gain insights into how to build internal alignment, maintain functional accountability, and develop standardized playbooks that can be adapted across programs. This topic is especially timely as companies face increasing pressure to optimize resource allocation and maximize the value of shelved or deprioritized assets.

The Path to Smarter, Streamlined Alliance Management with Optimized Digital Tools, Julie Settipani

1:35 - 1:55

Digitalization is a key component for alliance leaders to maximize the value of their alliance portfolios. This presentation explores the state of digitalization in alliance management across 20 top biopharmaceutical companies. Drawing from in-depth interviews, usage data, and real-world case studies, it introduces a practical framework to assess digital maturity across five key pillars. Attendees will gain a clear roadmap to move from manual, siloed practices to integrated, insight-driven alliance operations — and understand what digital alliance leaders are doing differently.

Operational Playbook: Avoiding Alliance Pitfalls in Emerging Biopharma, Tiffany Adams-Newsome

Beyond Metrics: Building Mindsets, Celebrating Milestones, and Shaping Reputation in Strategic Partnerships, Saghar Nourian

1:15 - 1:35

While KPIs remain essential for measuring partnership success, they're only part of the story—true collaboration impact requires understanding how success is achieved, who's involved, and how value is communicated. This session introduces a comprehensive framework that complements traditional metrics by integrating milestone storytelling, external reputation building, and mindset development to create stronger, more adaptive partnerships. Learn how strategic milestones like co-publications and regulatory achievements become powerful alignment tools when co-defined and celebrated, discover methods for leveraging these successes to build external visibility through compliant social media and thought leadership strategies, and explore how fostering continuous learning through feedback loops and retrospectives creates resilient partnership cultures. Participants will gain practical tools to complement KPIs with strategic milestones, strengthen external reputation through effective communication, and embed continuous improvement practices that shift from metrics-only approaches to meaning-driven partnerships where structure, storytelling, and shared values drive lasting success.

Standing Up Complex Investment-backed Alliances, Chris Bosworth, Jacqueline Dim, Alissa Fernald

1:35 - 1:55

This peer learning session provides practical insights into the critical phases of deal implementation, alliance governance design, and cross-functional collaboration that enable successful new company formation, while sharing how alliance managers have navigated the expanding scope of their roles beyond traditional boundaries within the NewCo model. Participants will gain actionable strategies for managing multi-stakeholder interests, establishing effective governance frameworks, and leading collaborative efforts across diverse partnership structures, making this essential learning for alliance professionals involved in complex venture formations or considering how their roles continue to evolve in innovative partnership models.

Transition Break

BREAKOUT TRACKS

Orchestrating Without a Baton: The Art of Alliance Leadership Without Authority, Swati Prasad

Today's alliance professionals are enterprise leaders operating in matrixed systems where formal authority is limited but stakes are high, making influence—not hierarchy—the critical success lever. This interactive session equips alliance leaders with advanced strategies for navigating uncertainty, misalignment, and complexity across diverse partnerships involving academic medical centers, venture-backed biotechs, global co-development partners, and foundations. Grounded in behavioral science and real-world alliance dynamics, learn to diagnose invisible influence barriers, activate stakeholder motivation amid competing priorities, reframe conflicting scientific narratives, and leverage informal channels when governance stalls. Through a live mini-case walkthrough and audience role-play, participants will apply key tools in real-time simulated governance conflicts, leaving with a practical influence toolkit to drive clarity across silos and lead complex partnerships with confidence and agility—essential skills for alliance professionals ready to expand their strategic voice and lead at the next level.

From Outsider to Insider: Lessons from a Newcomer's Journey Into Alliance Management, Claire Patterson

2:00 - 2:20

Discover how to successfully transition into alliance management from outside the discipline through one practitioner's journey from a non-traditional background into a global biopharma alliance role. This session shares practical strategies for rapid skill development, building credibility, and contributing to strategic partnerships without formal alliance management experience—including working remotely at a new company. Learn which fundamentals to prioritize first, how to leverage transferable skills for quick traction, the essential coaching and support needed for success, and strategies for engaging in cross-functional projects that build organizational visibility and trust. Perfect for professionals considering the transition and hiring managers looking to broaden their talent pipeline beyond traditional alliance management backgrounds.

Managing Complexity in Rare Disease Collaborations: Governance, Trust and Shared Goals, Nicole Le Grand, Rebecca Wilson

2:20 - 2:40

Discover how alliance management is transforming within rare disease through innovative partnership models that span geographies, sectors, and disciplines. This interactive session explores LifeArc's experience establishing a dedicated alliance management function—from mapping diverse partnership portfolios to building credibility as a distinct discipline—before examining their £40million Translational Centres programme uniting universities, clinical teams, charities, and funders nationwide. Learn practical strategies for balancing philanthropic funding with collaborative working, developing flexible governance models that maintain partner alignment on patient outcomes amid shifting landscapes, and successfully embedding new alliance teams while bringing multiple stakeholders together around shared rare disease goals.

Living Beyond the Contract: New Frontiers in Partnership Success, Tyson Bertmaring, Christine Klatt, Monique Yoakim-Turk, Kara McCarthy Perry, Sue Feury

What if partnership success depended less on complex contracts and more on shared outcomes? This transformative session challenges traditional alliance frameworks by exploring innovative approaches to value creation that foster deeper collaboration, agility, and mutual growth in complex, dynamic markets. Discover pioneering strategies that move beyond conventional alliance management toward integrated partnership success models, where professionals take broad strategic approaches to proactively drive desired outcomes rather than simply managing agreements. Learn how thinking beyond contractual structures unlocks new possibilities for meaningful collaboration and sustainable value creation that benefits all partners.

Ask Me Anything, Jeremy Ahouse

Afternoon Break

Alliance Leadership in Anxious Times, Jan Twombly

The biopharmaceutical industry faces unprecedented uncertainty—from research funding cuts and regulatory volatility to supply chain shocks—while alliance leaders must deliver differentiated value with fewer resources amid exciting new partnerships between unusual partners. Drawing from recent experiences and research, this session examines how leaders can foster resilience and agility among alliance teams and governance committees, enhance operations, and align stakeholder interests to drive success in anxious times. Participants will gain specific strategies for empowering alliance teams to self-manage without losing visibility, techniques for navigating sudden resource losses, and methods for maintaining stability and confidence while leading alliances through organizational change and external disruptions—essential skills for alliance professionals operating in today's complex, dynamic environment.

Alliance Dynamics: Driving Success in Early Research Partnerships, Elnaz Atabakhsh, Karen Berna, Kevin Little, Kristin Rosner

As biopharmaceutical research complexity increases, pharma companies can no longer conduct innovation programs in isolation, driving unprecedented growth in early research partnerships with academia and biotech. This multi-perspective session brings together industry leaders to share how different companies structure and execute successful early research collaborations that solve and treat complex diseases. Explore diverse partnership models, examine both contractual frameworks and cultural considerations that enable effective collaboration, and discover practical strategies for building the relationships that fuel today's most innovative research programs in an increasingly interconnected biopharma ecosystem.

Managing Risk in Strategic BioPharma Alliances: Practical Tools, Real Impact, Samuel Gosselin, Sharon Morgenbesser

This session transforms how risk is understood, communicated, and addressed within biopharma partnerships by demystifying alliance risk management for cross-functional stakeholders beyond alliance management. Learn specific processes and tools alliance professionals use to monitor, triage, and escalate risks effectively, while discovering how legal, finance, BD, corporate strategy, clinical development, and commercial teams can partner more strategically with alliance teams. Gain practical insights into embedding risk management within successful alliances and develop skills to mitigate risks early, strategically, and constructively through enhanced cross-functional collaboration that strengthens partnership outcomes. 

Increase Your Chance of Successful Integration Following Acquisition, Aida Bendt, Romuald Laine

This session explores critical decision-making around inherited alliances when programs compete with internal initiatives, practical strategies for managing deal milestones and operational transfers, and the unique challenges of establishing a new R&D lab in Boston for transferred research staff under pandemic constraints. Gain insights into the multifaceted reality of M&A integration where alliance management intersects with operational complexity, strategic portfolio decisions, and crisis management in today's unpredictable business environment. 

Networking Reception

Afterglow Reception (all invited) - Sponsored by Vantage Partners

KEYNOTE - Building Strategic Alliances for Breakthrough AI Innovation, Sarah Korman

The rise of AI is redefining the boundaries of what is possible in drug discovery and development. Yet no single company can realize this potential alone. In this keynote, Sarah Korman, PhD JD, Chief Business and Legal Officer at Isomorphic Labs, will explore how alliances are becoming critical accelerators of innovation in an AI-driven world.

Drawing on her cross-disciplinary expertise in intellectual property, biopharma operations, and frontier AI applications, Sarah will highlight how companies can structure partnerships that deliver scalable impact—balancing speed, trust, and governance while navigating a rapidly shifting scientific and regulatory landscape. She will share lessons from building collaborations at the intersection of AI and life sciences and offer a forward-looking perspective on how alliance professionals can position themselves to unlock new value for patients, partners, and the broader ecosystem.
This session will set the stage for a day focused on where alliance management is heading next—towards scalable, AI-powered, and patient-centered innovation.

AI in Action: Simplifying Alliance Management for Greater Influence and Impact, Louis Rinfret

While AI promises industry revolution, its real value emerges through practical applications already simplifying alliance management for leading biopharma organizations. This interactive session demonstrates how AI is streamlining operations and enhancing strategic decision-making, showing you firsthand how these tools can elevate your alliances and drive measurable outcomes. Move beyond AI hype to discover actionable applications you can implement in your day-to-day work, gaining practical knowledge that boosts your influence and impact while positioning your alliance management function at the forefront of digital transformation in biopharma partnerships.

ASAP Roundtable Topic Discussions

1. Alliance Leaders as Strategic and Trusted Advisors
   Explore how alliance leaders can elevate their role from operational execution to trusted advisors influencing corporate strategy.
2. AI in Alliance Management
   Discuss where artificial intelligence is making the biggest impact—from forecasting and decision-making to decentralized models—and how alliances can accelerate adoption.
3. Digital Health Partnerships
   Examine how digital platforms, decentralized trial designs, and real-world data tools are transforming collaboration and patient access.
4. Redefining Success Metrics
   Consider how alliances should measure success beyond financial milestones, including patient outcomes, innovation speed, and ecosystem value.
5. Navigating the Biotech–Big Pharma Divide, Table Facilitator:  Anna Skabeev, Teva
   Share strategies to bridge cultural, structural, and scale differences between emerging biotechs and established pharma companies.
6. Leadership in Times of Disruption
   Examine how leaders can maintain partner trust while navigating M&A, shifting pipelines, and external pressures.
7. The Future of Data Ecosystems
   Debate governance, intellectual property, and data-sharing models that enable collaboration while protecting value.
8. Patient-Centric Partnerships
   Explore how alliances can integrate patient voices and needs directly into R&D, clinical trials, and commercialization.
9. Global Headwinds & Geopolitical Climate
   Reflect on how regulatory shifts, supply chain challenges, and geopolitical dynamics are shaping the future of global alliances.
10. Education, Research & the Next Generation of Innovation, Table Facilitator:  Carly Cederquist, PhD, CA-AM, Harvard University, Office of Technology Development
    Discuss how academia, industry, and training programs can collaborate to advance research and prepare future talent for evolving alliance roles.

Navigating Challenging Alliance Dynamics – A Conversation, Moderated by Erin Gibson with Lauren Griffey, Nick Marchese, Cindy Yang

Alliances are vital to driving innovation. Yet, alliances often encounter challenges stemming from organizational disparities, cultural mismatches, and the interpersonal dynamics of the cross-company teams. In this panel, we will explore real-world examples, highlighting key obstacles that emerged and how alliance teams navigated them. Panelists will share candid insights into strategies they implemented to address challenges, and what worked—or didn’t. Attendees will gain practical takeaways, including lessons learned through retrospective reviews, that can help improve alliance outcomes.

Driving Alliance Performance Through Commercial Quarterly Business Reviews, Sonia Espana, Yaminah Leggett-Wells

Alliances are vital to driving innovation. Yet, alliances often encounter challenges stemming from organizational disparities, cultural mismatches, and the interpersonal dynamics of the cross-company teams. In this panel, we will explore real-world examples, highlighting key obstacles that emerged and how alliance teams navigated them. Panelists will share candid insights into strategies they implemented to address challenges, and what worked—or didn’t. Attendees will gain practical takeaways, including lessons learned through retrospective reviews, that can help improve alliance outcomes.

Alliance for Air:  Driving Strategic Execution and Shared Success, Craig McDonald

Every great partnership has a story. For Chiesi and Gossamer Bio, it begins with a shared vision: turning scientific promise into life-changing therapies for patients with serious, progressive, and life-threatening cardiopulmonary diseases worldwide. Yet vision alone isn’t enough. Successful biopharma partnerships are built on execution and how the organizations combine respective competencies, align, adapt, and deliver together.

This presentation delves into the strategic collaboration between Chiesi and Gossamer Bio, highlighting how effective alliance management practices are driving scientific and business success, while creating long-term value for both partners.

The session will highlight how close collaboration coupled with cross-functional alignment, robust governance and a shared commitment to innovation help alliances translate scientific potential into meaningful advancements despite significant differences in size and culture.

Key Takeaways

• Learn why a bold, unified purpose is the foundation for aligning diverse organizations and motivating teams.
• Discover how governance, operational discipline, and integrated execution are essential for overcoming partnership challenges and sustaining momentum.
• Recognize that partnerships thrive when alliance leaders cultivate trust, transparent communication, and responsiveness to achieve long-term mutual benefit.